CAR-T: The Designer Tumor Therapy Frontier
Personalized medicine is taking new and powerful forms in the field of immunotherapy. The technology behind making customized tumor-destroying cells, thought of not long...
Streetwise Reports Examines How A Development Agreement for Permian Basin Acreage Would Eliminate Capex Budget
The letter of intent signed to develop this oil & gas company's large acreage in the red-hot Permian Basin would not only eliminate the...
Ultragenyx and Kyowa Kirin Announce Positive 48-Week Data from Adult Phase 3 Study of Burosumab in X-Linked Hypophosphatemia
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, Kyowa Hakko Kirin Co.,...
FDA Approves Amgen’s Repatha® (evolocumab) To Prevent Heart Attack And Stroke
Amgen announced that following priority review of its supplemental Biologics License Application, the U.S. Food and Drug Administration (FDA) approved Repatha® (evolocumab) as the...
ViiV Healthcare begins phase III study of long-acting cabotegravir for HIV prevention in women
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, announced the start of HPTN...
FDA grants orphan drug status to Shire’s UC treatment SHP647
The US Food and Drug Administration (FDA) has granted orphan drug designation to Shire’s investigational mucosal addressin cell adhesion molecule-1 (MAdCAM-1) antibody, SHP647, for...
NeuroVive’s genetic mitochondrial disease program NVP015 reaches significant milestone
NeuroVive Pharmaceutical AB, the mitochondrial medicine company, announced that molecules in its NVP015 program have demonstrated positive effects in experimental models of genetic mitochondrial...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...